Peregrin
Homo sapiens
State in the Current Structure
| Assembly | Oligomeric State | Construct | Mutations and Modifications | Ligands, Ions and Associated Components | Method and Experimental Conditions | Structure Quality |
|---|---|---|---|---|---|---|
| 1 | Protein heterocomplex Heteromer Protein × 2 PDB declaration: dimeric（2） Consistent with protein copy count | Chain A； UniProt 1079–1207 | Fragment：UNP residues 1079-1207 | Histone H3.2 TRIMETHYLATED H3K36 PEPTIDE × 1 （Q71DI3） | X-RAY DIFFRACTION X-ray crystallization conditions：VAPOR DIFFUSION, SITTING DROP；pH 8.5；293 K；3.5M sodium formate, 0.1M Tris-HCl pH8.5, H3K36me3 peptide, VAPOR DIFFUSION, SITTING DROP, temperature 293K | Resolution 1.69 Å R-free 0.207 |
Other States of the Same Protein in the Database
Each row is a biological assembly of the same UniProt protein in another PDB entry. The “Difference from current entry” column identifies evidence-level differences; no tag means the currently parsed fields agree.
| Other PDB | Difference from Current Entry 3MO8 | Assembly / Oligomeric State | Construct | Mutations and Modifications | Ligands, Ions and Non-polymers | Method and Experimental Conditions | Structure Quality |
|---|---|---|---|---|---|---|---|
| 2RS9 Solution structure of the bromodomain of human BRPF1 in complex with histone H4K5ac peptide Deposited 2011-12-08 | Different construct Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer；Protein × 2 PDB declaration: dimeric |
Chain B
633–740（108 aa）
Fragment：Bromodomain, UNP residues 633-740
|
Not recorded | No recorded non-water small molecule |
SOLUTION NMR
NMR measurement conditions
pH 6.5；288 K；Ionic strength (raw mmCIF value) 100；Pressure ambient
NMR sample composition
1.5 mM H4K5ac-1, 0.54 mM [U-99% 13C; U-99% 15N] Bromodomain-2, 90% H2O/10% D2O | 90% H2O/10% D2O
|
Resolution not provided |
| 2X35 Molecular basis of Histone H3K36me3 recognition by the PWWP domain of BRPF1. Deposited 2010-01-21 | Different construct Different oligomeric state Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric |
Chain A
1076–1205（130 aa）
Fragment：BRPF1 PWWP DOMAIN, RESIDUES 1076-1205
|
Not recorded | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 8.5；20% PEG 3350, 0.2M LITHIUM SULPHATE, 0.1M TRIS (PH 8.5), 10 MM NACL
|
Resolution 2.00 Å R-free 0.236 |
| 2X4W Molecular basis of Histone H3K36me3 recognition by the PWWP domain of BRPF1. Deposited 2010-02-02 | Different construct Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer；Protein × 2 PDB declaration: dimeric |
Chain A
1076–1205（130 aa）
Fragment：RESIDUES 1076-1205
|
Not recorded | FMT FORMIC ACID × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 8.5；4M SODIUM FORMATE, 0.1M TRIS (PH 8.5), 0.01M NACL
|
Resolution 1.50 Å R-free 0.216 |
| 2X4X Molecular basis of Histone H3K36me3 recognition by the PWWP domain of BRPF1. Deposited 2010-02-02 | Different construct Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer；Protein × 2 PDB declaration: dimeric |
Chain E
1076–1205（130 aa）
Fragment：BRPF1 PWWP DOMAIN, RESIDUES 1076-1205
|
Not recorded | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 8.5；20% PEG3350, 0.2M LITHIUM SULPHATE, 0.1M TRIS (PH 8.5) 0.01M NACL
|
Resolution 1.85 Å R-free 0.239 |
| 2X4X Molecular basis of Histone H3K36me3 recognition by the PWWP domain of BRPF1. Deposited 2010-02-02 | Different construct Different experimental conditions Different structure-quality metrics | Assembly 2 Protein heterocomplex Heteromer；Protein × 2 PDB declaration: dimeric |
Chain C
1076–1205（130 aa）
Fragment：BRPF1 PWWP DOMAIN, RESIDUES 1076-1205
|
Not recorded | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 8.5；20% PEG3350, 0.2M LITHIUM SULPHATE, 0.1M TRIS (PH 8.5) 0.01M NACL
|
Resolution 1.85 Å R-free 0.239 |
| 2X4X Molecular basis of Histone H3K36me3 recognition by the PWWP domain of BRPF1. Deposited 2010-02-02 | Different construct Different experimental conditions Different structure-quality metrics | Assembly 3 Protein heterocomplex Heteromer；Protein × 2 PDB declaration: dimeric |
Chain G
1076–1205（130 aa）
Fragment：BRPF1 PWWP DOMAIN, RESIDUES 1076-1205
|
Not recorded | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 8.5；20% PEG3350, 0.2M LITHIUM SULPHATE, 0.1M TRIS (PH 8.5) 0.01M NACL
|
Resolution 1.85 Å R-free 0.239 |
| 2X4X Molecular basis of Histone H3K36me3 recognition by the PWWP domain of BRPF1. Deposited 2010-02-02 | Different construct Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 4 Protein heterocomplex Heteromer；Protein × 2 PDB declaration: dimeric |
Chain A
1076–1205（130 aa）
Fragment：BRPF1 PWWP DOMAIN, RESIDUES 1076-1205
|
Not recorded | SO4 SULFATE ION × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 8.5；20% PEG3350, 0.2M LITHIUM SULPHATE, 0.1M TRIS (PH 8.5) 0.01M NACL
|
Resolution 1.85 Å R-free 0.239 |
| 2X4Y Molecular basis of Histone H3K36me3 recognition by the PWWP domain of BRPF1. Deposited 2010-02-02 | Different construct Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer；Protein × 2 PDB declaration: dimeric |
Chain O
1076–1205（130 aa）
Fragment：BRPF1 PWWP DOMAIN, RESIDUES 1076-1205
|
Not recorded | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 8.5；30% PEG4K, 0.2M LITHIUM SULPHATE, 0.1M TRIS (PH 8.5), 0.01M NACL.
|
Resolution 1.70 Å R-free 0.227 |
| 2X4Y Molecular basis of Histone H3K36me3 recognition by the PWWP domain of BRPF1. Deposited 2010-02-02 | Different construct Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Protein heterocomplex Heteromer；Protein × 2 PDB declaration: dimeric |
Chain E
1076–1205（130 aa）
Fragment：BRPF1 PWWP DOMAIN, RESIDUES 1076-1205
|
Not recorded | SO4 SULFATE ION × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 8.5；30% PEG4K, 0.2M LITHIUM SULPHATE, 0.1M TRIS (PH 8.5), 0.01M NACL.
|
Resolution 1.70 Å R-free 0.227 |
| 2X4Y Molecular basis of Histone H3K36me3 recognition by the PWWP domain of BRPF1. Deposited 2010-02-02 | Different construct Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 3 Protein heterocomplex Heteromer；Protein × 2 PDB declaration: dimeric |
Chain C
1076–1205（130 aa）
Fragment：BRPF1 PWWP DOMAIN, RESIDUES 1076-1205
|
Not recorded | SO4 SULFATE ION × 2 |
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 8.5；30% PEG4K, 0.2M LITHIUM SULPHATE, 0.1M TRIS (PH 8.5), 0.01M NACL.
|
Resolution 1.70 Å R-free 0.227 |
| 2X4Y Molecular basis of Histone H3K36me3 recognition by the PWWP domain of BRPF1. Deposited 2010-02-02 | Different construct Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 4 Protein heterocomplex Heteromer；Protein × 2 PDB declaration: dimeric |
Chain G
1076–1205（130 aa）
Fragment：BRPF1 PWWP DOMAIN, RESIDUES 1076-1205
|
Not recorded | SO4 SULFATE ION × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 8.5；30% PEG4K, 0.2M LITHIUM SULPHATE, 0.1M TRIS (PH 8.5), 0.01M NACL.
|
Resolution 1.70 Å R-free 0.227 |
| 2X4Y Molecular basis of Histone H3K36me3 recognition by the PWWP domain of BRPF1. Deposited 2010-02-02 | Different construct Different experimental conditions Different structure-quality metrics | Assembly 5 Protein heterocomplex Heteromer；Protein × 2 PDB declaration: dimeric |
Chain K
1076–1205（130 aa）
Fragment：BRPF1 PWWP DOMAIN, RESIDUES 1076-1205
|
Not recorded | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 8.5；30% PEG4K, 0.2M LITHIUM SULPHATE, 0.1M TRIS (PH 8.5), 0.01M NACL.
|
Resolution 1.70 Å R-free 0.227 |
| 2X4Y Molecular basis of Histone H3K36me3 recognition by the PWWP domain of BRPF1. Deposited 2010-02-02 | Different construct Different experimental conditions Different structure-quality metrics | Assembly 6 Protein heterocomplex Heteromer；Protein × 2 PDB declaration: dimeric |
Chain M
1076–1205（130 aa）
Fragment：BRPF1 PWWP DOMAIN, RESIDUES 1076-1205
|
Not recorded | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 8.5；30% PEG4K, 0.2M LITHIUM SULPHATE, 0.1M TRIS (PH 8.5), 0.01M NACL.
|
Resolution 1.70 Å R-free 0.227 |
| 2X4Y Molecular basis of Histone H3K36me3 recognition by the PWWP domain of BRPF1. Deposited 2010-02-02 | Different construct Different experimental conditions Different structure-quality metrics | Assembly 7 Protein heterocomplex Heteromer；Protein × 2 PDB declaration: dimeric |
Chain I
1076–1205（130 aa）
Fragment：BRPF1 PWWP DOMAIN, RESIDUES 1076-1205
|
Not recorded | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 8.5；30% PEG4K, 0.2M LITHIUM SULPHATE, 0.1M TRIS (PH 8.5), 0.01M NACL.
|
Resolution 1.70 Å R-free 0.227 |
| 2X4Y Molecular basis of Histone H3K36me3 recognition by the PWWP domain of BRPF1. Deposited 2010-02-02 | Different construct Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 8 Protein heterocomplex Heteromer；Protein × 2 PDB declaration: dimeric |
Chain A
1076–1205（130 aa）
Fragment：BRPF1 PWWP DOMAIN, RESIDUES 1076-1205
|
Not recorded | SO4 SULFATE ION × 3 |
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 8.5；30% PEG4K, 0.2M LITHIUM SULPHATE, 0.1M TRIS (PH 8.5), 0.01M NACL.
|
Resolution 1.70 Å R-free 0.227 |
| 3L42 PWWP domain of human bromodomain and PHD finger containing protein 1 Deposited 2009-12-18 | Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric |
Chain A
1079–1207（129 aa）
Fragment：UNP residues 1079-1207
|
Not recorded | UNX UNKNOWN LIGAND × 3 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION；pH 8.5；291 K；3.5M sodium formate, 0.1M TRIS-hydrochloride, pH 8.5, vapor diffusion, temperature 291K
X-ray crystallization conditions
VAPOR DIFFUSION；pH 7.5；291 K；25% PEG3350, 0.1M ammonium sulfate, 0.1M HEPES, pH 7.5, vapor diffusion, temperature 291K
|
Resolution 1.30 Å R-free 0.233 |
| 4LC2 Crystal structure of the bromodomain of human BRPF1B Deposited 2013-06-21 | Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric |
Chain A
626–740（115 aa）
Fragment：unp residues 626-740
|
Not recorded | NO3 NITRATE ION × 1 EDO 1,2-ETHANEDIOL × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP；pH 7.8；277 K；20% PEG3350
0.1 M bis tris propane, 10% ethylene glycol
0.15 M sodium nitrate, pH 7.8, VAPOR DIFFUSION, SITTING DROP, temperature 277K
|
Resolution 1.65 Å R-free 0.220 |
| 4QYD Crystal Structure of the human BRPF1 bromodomain in complex with a histone H4K12ac peptide Deposited 2014-07-24 | Different construct Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer；Protein × 2 PDB declaration: dimeric |
Chain A
629–742（114 aa）
Fragment：bromodomain (UNP residues 629-742)
|
Not recorded | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 7.5；277 K；0.1 M HEPES, pH 7.5, 10% w/v polyethylene glycol (PEG) 6,000, 5% v/v (+/-)-2-methyl-2,4-pentanediol (MPD), VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 1.94 Å R-free 0.213 |
| 4QYL Crystal Structure of the human BRPF1 bromodomain in complex with a histone H2AK5ac peptide Deposited 2014-07-24 | Different construct Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer；Protein × 2 PDB declaration: dimeric |
Chain A
629–742（114 aa）
Fragment：bromodomain (UNP residues 629-742)
|
Not recorded | SO4 SULFATE ION × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP；pH 6.5；277 K；0.2 M NH4SO4, 0.1 M MES monohydrate, pH 6.5, 30% w/v polyethylene glycol monomethyl ether (PEG) 5000, 1% propylene glycol, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 1.80 Å R-free 0.253 |
| 4QYL Crystal Structure of the human BRPF1 bromodomain in complex with a histone H2AK5ac peptide Deposited 2014-07-24 | Different construct Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Protein heterocomplex Heteromer；Protein × 2 PDB declaration: dimeric |
Chain B
629–742（114 aa）
Fragment：bromodomain (UNP residues 629-742)
|
Not recorded | SO4 SULFATE ION × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP；pH 6.5；277 K；0.2 M NH4SO4, 0.1 M MES monohydrate, pH 6.5, 30% w/v polyethylene glycol monomethyl ether (PEG) 5000, 1% propylene glycol, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 1.80 Å R-free 0.253 |
| 4QYL Crystal Structure of the human BRPF1 bromodomain in complex with a histone H2AK5ac peptide Deposited 2014-07-24 | Different construct Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 3 Protein heterocomplex Heteromer；Protein × 2 PDB declaration: dimeric |
Chain C
629–742（114 aa）
Fragment：bromodomain (UNP residues 629-742)
|
Not recorded | SO4 SULFATE ION × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP；pH 6.5；277 K；0.2 M NH4SO4, 0.1 M MES monohydrate, pH 6.5, 30% w/v polyethylene glycol monomethyl ether (PEG) 5000, 1% propylene glycol, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 1.80 Å R-free 0.253 |
| 4QYL Crystal Structure of the human BRPF1 bromodomain in complex with a histone H2AK5ac peptide Deposited 2014-07-24 | Different construct Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 4 Protein heterocomplex Heteromer；Protein × 2 PDB declaration: dimeric |
Chain D
629–742（114 aa）
Fragment：bromodomain (UNP residues 629-742)
|
Not recorded | SO4 SULFATE ION × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP；pH 6.5；277 K；0.2 M NH4SO4, 0.1 M MES monohydrate, pH 6.5, 30% w/v polyethylene glycol monomethyl ether (PEG) 5000, 1% propylene glycol, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 1.80 Å R-free 0.253 |
| 4UYE BROMODOMAIN OF HUMAN BRPF1 WITH N-1,3-dimethyl-2-oxo-6-(piperidin-1- yl)-2,3-dihydro-1H-1,3-benzodiazol-5-yl-2-methoxybenzamide Deposited 2014-08-30 | Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric |
Chain A
622–738（117 aa）
Fragment：BROMODOMAIN, UNP RESIDUES 622-738
|
Not recorded | EDO 1,2-ETHANEDIOL × 1 9F9 N-[1,3-dimethyl-2-oxo-6-(piperidin-1-yl)-2,3-dihydro-1H-benzimidazol-5-yl]-2-methoxybenzamide × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 6.5；0.1 M MES/IMIDAZOLE PH 6.5, 10% MORPHEUS DIVALENTS MPD_P1K_P3350
|
Resolution 1.65 Å R-free 0.201 |
| 4UYE BROMODOMAIN OF HUMAN BRPF1 WITH N-1,3-dimethyl-2-oxo-6-(piperidin-1- yl)-2,3-dihydro-1H-1,3-benzodiazol-5-yl-2-methoxybenzamide Deposited 2014-08-30 | Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric |
Chain B
622–738（117 aa）
Fragment：BROMODOMAIN, UNP RESIDUES 622-738
|
Not recorded | 9F9 N-[1,3-dimethyl-2-oxo-6-(piperidin-1-yl)-2,3-dihydro-1H-benzimidazol-5-yl]-2-methoxybenzamide × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 6.5；0.1 M MES/IMIDAZOLE PH 6.5, 10% MORPHEUS DIVALENTS MPD_P1K_P3350
|
Resolution 1.65 Å R-free 0.201 |
| 5C6S Human Bromodomain and PHD Finger Containing 1, PWWP domain in complex with XST005904a Deposited 2015-06-23 | Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric |
Chain A
1079–1207（129 aa）
Fragment：PWWP domain (UNP residues 1079-1207)
|
Not recorded | 4K8 isoquinoline-3-carboxylic acid × 1 CL CHLORIDE ION × 1 EPE 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID × 1 UNX UNKNOWN LIGAND × 15 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP；pH 7.5；293 K；25% PEG 3350, 0.2M LiSO4, 0.1M HEPES pH7.5
|
Resolution 1.30 Å R-free 0.217 |
| 5C7N Crystal structure of the human BRPF1 bromodomain in complex with Bromosporine Deposited 2015-06-24 | Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric |
Chain A
626–740（115 aa）
Fragment：residues 626-740
|
Not recorded | BMF Bromosporine × 1 NO3 NITRATE ION × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP；pH 5.5；277 K；20% PEG3350, 0.1 M sodium acetate, 0.15 M sodium nitrate, pH 5.5
|
Resolution 1.75 Å R-free 0.221 |
| 5C85 Crystal structure of the human BRPF1 bromodomain in complex with SEED1 Deposited 2015-06-25 | Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric |
Chain A
626–740（115 aa）
|
Not recorded | NO3 NITRATE ION × 1 4YO 6-bromo-3,4-dihydroquinoxalin-2(1H)-one × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP；277 K；0.1 M Bis-Tris propane, pH6.5, 0.2 M sodium nitrate, 20%PEG33500
|
Resolution 1.70 Å R-free 0.226 |
| 5C87 Crystal structure of the human BRPF1 bromodomain in complex with SEED2 Deposited 2015-06-25 | Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric |
Chain A
626–740（115 aa）
Fragment：residues 626-740
|
Not recorded | NO3 NITRATE ION × 1 4YS isoquinolin-1(2H)-one × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP；277 K；0.1 M Bis-Tris propane, pH6.5, 0.2 M sodium nitrate, 20%PEG33500
|
Resolution 1.55 Å R-free 0.198 |
| 5C89 Crystal structure of the human BRPF1 bromodomain in complex with 917 Deposited 2015-06-25 | Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric |
Chain A
627–740（114 aa）
|
Not recorded | 4YT 1-ethyl-8-methoxy-5-methyl[1,2,4]triazolo[4,3-a]quinoline × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP；277 K；0.1M sodium acetate, pH 5.5, 0.15 M potassium thiocynate, 20% PEG3350
|
Resolution 1.65 Å R-free 0.200 |
| 5D7X Crystal structure of the human BRPF1 bromodomain in complex with XZ08 Deposited 2015-08-14 | Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric |
Chain A
626–740（115 aa）
Fragment：UNP residues 626-740
|
Not recorded | NO3 NITRATE ION × 1 XZ8 4-(1-acetyl-1H-indol-3-yl)-5-methyl-1,2-dihydro-3H-pyrazol-3-one × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP；pH 6.5；277 K；0.1 M Bis-Tris Propane, pH6.5, 0.2M Sodium Nitrate, 20% PEG3350
|
Resolution 1.35 Å R-free 0.176 |
| 5DY7 Crystal structure of the human BRPF1 bromodomain in complex with SEED4 Deposited 2015-09-24 | Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric |
Chain A
626–740（115 aa）
|
Not recorded | 5GT 7-(trifluoromethyl)-3,4-dihydroquinoxalin-2(1H)-one × 1 NO3 NITRATE ION × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP；pH 5.5；277 K；0.1M Sodium Acetate, pH5.5, 0.15 M Sodium Nitrate, 20% PEG3350
|
Resolution 1.69 Å R-free 0.204 |
| 5DYA Crystal structure of the human BRPF1 bromodomain in complex with SEED5 Deposited 2015-09-24 | Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric |
Chain A
625–740（116 aa）
Fragment：UNP residues 625-740
|
Not recorded | NO3 NITRATE ION × 1 5GV (2R)-2-ethyl-3-oxo-1,2,3,4-tetrahydroquinoxaline-6-carboxylic acid × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP；pH 5.5；277 K；0.1M Sodium Acetate, pH5.5, 0.15 M Sodium Nitrate, 20% PEG3350
|
Resolution 1.65 Å R-free 0.214 |
| 5DYC Crystal structure of the human BRPF1 bromodomain in complex with SEED6 Deposited 2015-09-24 | Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric |
Chain A
625–740（116 aa）
Fragment：UNP residues 625-740
|
Not recorded | NO3 NITRATE ION × 1 5GU 7-bromo-3,4-dihydroquinoxalin-2(1H)-one × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP；277 K；0.1M Sodium Acetate, pH5.5, 0.15 M Sodium Nitrate, 20% PEG3350
|
Resolution 1.65 Å R-free 0.235 |
| 5E3D Crystal structure of the human BRPF1 bromodomain in complex with SEED7 Deposited 2015-10-02 | Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric |
Chain A
626–740（115 aa）
Fragment：UNP residues 626-740
|
Not recorded | 5JL 2,8-dithioxo-1,2,3,7,8,9-hexahydro-6H-purin-6-one × 1 NO3 NITRATE ION × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP；pH 5.5；277 K；0.1 M Sodium Acetate, pH5.5, 0.15 M Sodium Nitrate, 20% PEG3350
|
Resolution 1.71 Å R-free 0.222 |
| 5E3G Crystal structure of the human BRPF1 bromodomain in complex with SEED8 Deposited 2015-10-02 | Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric |
Chain A
626–740（115 aa）
Fragment：UNP residues 626-740
|
Not recorded | 5JQ 2-thioxo-2,3,7,9-tetrahydro-1H-purine-6,8-dione × 1 NO3 NITRATE ION × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP；277 K；0.1 M Sodium Acetate, pH 5.5, 0.15 M Sodium Nitrate, 20% PEG3350
|
Resolution 1.65 Å R-free 0.205 |
| 5EM3 Crystal structure of the human BRPF1 bromodomain in complex with SEED9 Deposited 2015-11-05 | Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric |
Chain A
626–740（115 aa）
Fragment：UNP residues 626-740
|
Not recorded | 5Q0 quinolin-5-ol × 2 NO3 NITRATE ION × 2 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP；277 K；0.1 M Sodium-Acetate, pH5.5, 0.15 M Sodium Nitrate, 20% PEG3350
|
Resolution 1.40 Å R-free 0.188 |
| 5EPR Crystal structure of the human BRPF1 bromodomain in complex with SEED11 Deposited 2015-11-12 | Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric |
Chain A
626–740（115 aa）
Fragment：UNP residues 626-740
|
Not recorded | 5QY (3~{S})-3-methyl-3,4-dihydro-1~{H}-quinoxalin-2-one × 1 NO3 NITRATE ION × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP；277 K；0.1 M Sodium Acetate, pH5.5, 0.15 M Sodium Nitrate, 20% PEG3350
|
Resolution 1.65 Å R-free 0.220 |
| 5EPS Crystal structure of the human BRPF1 bromodomain in complex with SEED10 Deposited 2015-11-12 | Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric |
Chain A
627–740（114 aa）
Fragment：UNP residues 625-740
|
Not recorded | 5QX 1-methyl-3,4-dihydroquinoxalin-2-one × 1 NO3 NITRATE ION × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP；pH 5.5；277 K；0.1 M Sodium Acetate, pH5.5, 0.15 M Sodium Nitrate, 20% PEG3350
|
Resolution 1.47 Å R-free 0.198 |
| 5EQ1 Crystal structure of the human BRPF1 bromodomain in complex with SEED12 Deposited 2015-11-12 | Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric |
Chain A
626–740（115 aa）
Fragment：UNP residues 626-740
|
Not recorded | BEA 5-METHYL-1,2,4-TRIAZOLO[3,4-B]BENZOTHIAZOLE × 1 NO3 NITRATE ION × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP；277 K；0.1 M Bis-tris propane, pH6.5, 0.2 M Sodium nitrate, 20% PEG3350
|
Resolution 1.55 Å R-free 0.194 |
| 5ERC X-ray crystal structure of BRPF1 PZP domain Deposited 2015-11-13 | Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric |
Chain A
274–450（177 aa）
Fragment：PZP domain (UNP residues 274-450)
|
Not recorded | ZN ZINC ION × 5 CA CALCIUM ION × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP；pH 8；293 K；0.2 M Calcium acetate, 0.1 M Imidazole pH 8.0, 10% PEG8000
|
Resolution 2.05 Å R-free 0.193 |
| 5ETB Crystal structure of the human BRPF1 bromodomain in complex with SEED13 Deposited 2015-11-17 | Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric |
Chain A
626–740（115 aa）
Fragment：UNP residues 626-740
|
Not recorded | 5RO 1-(7-methyl-1~{H}-indol-3-yl)ethanone × 1 NO3 NITRATE ION × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP；277 K；0.1 M Bis-tris propane, pH6.5, 0.2 M Sodium nitrate, 20% PEG3350
|
Resolution 1.33 Å R-free 0.187 |
| 5ETD Crystal structure of the human BRPF1 bromodomain in complex with SEED14 Deposited 2015-11-17 | Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric |
Chain A
626–740（115 aa）
Fragment：UNP residues 626-740
|
Not recorded | 5RN 1-(1~{H}-indol-3-yl)ethanone × 1 NO3 NITRATE ION × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP；277 K；0.1 M Bis-tris propane, pH6.5, 0.2 M Sodium nitrate, 20% PEG3350
|
Resolution 1.40 Å R-free 0.187 |
| 5EV9 Crystal structure of the human BRPF1 bromodomain in complex with SEED15 Deposited 2015-11-19 | Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric |
Chain A
626–740（115 aa）
Fragment：UNP residues 626-740
|
Not recorded | 5SB ~{N}-[5-(1~{H}-pyrazol-4-yl)quinolin-8-yl]ethanamide × 1 NO3 NITRATE ION × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP；277 K；0.1M Sodium Acetate, pH5.5, 0.15 M Sodium Nitrate, 20% PEG3350
|
Resolution 1.45 Å R-free 0.221 |
| 5EVA Crystal structure of the human BRPF1 bromodomain in complex with SEED16 Deposited 2015-11-19 | Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric |
Chain A
626–740（115 aa）
Fragment：UNP residues 626-740
|
Not recorded | 5S9 ~{N}-[2,4-bis(fluoranyl)phenyl]-2-methyl-pyrazole-3-carboxamide × 1 NO3 NITRATE ION × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP；277 K；0.1 M Bis-tris propane, pH6.5, 0.2 M Sodium nitrate, 20% PEG3350
|
Resolution 1.45 Å R-free 0.198 |
| 5EWC Crystal structure of the human BRPF1 bromodomain in complex with SEED17 Deposited 2015-11-20 | Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric |
Chain A
626–740（115 aa）
Fragment：UNP residues 626-740
|
Not recorded | 5SJ ethyl (2~{R})-2-methyl-3-oxidanylidene-2,4-dihydro-1~{H}-quinoxaline-6-carboxylate × 1 NO3 NITRATE ION × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP；277 K；0.1M Sodium Acetate, pH5.5, 0.15 M Sodium Nitrate, 20% PEG3350
|
Resolution 1.75 Å R-free 0.211 |
| 5EWD Crystal structure of the human BRPF1 bromodomain in complex with SEED18 Deposited 2015-11-20 | Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric |
Chain A
626–740（115 aa）
Fragment：UNP residues 626-740
|
Not recorded | 5SH 4-phenylpyridine × 1 NO3 NITRATE ION × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP；277 K；0.1M Sodium Acetate, pH5.5, 0.15 M Sodium Nitrate, 20% PEG3350
|
Resolution 1.58 Å R-free 0.226 |
| 5EWH Crystal structure of the human BRPF1 bromodomain in complex with SEED19 Deposited 2015-11-20 | Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric |
Chain A
626–740（115 aa）
Fragment：UNP residues 626-740
|
Not recorded | 5SG isoquinolin-5-ol × 1 NO3 NITRATE ION × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP；277 K；0.1M Sodium Acetate, pH5.5, 0.15 M Sodium Nitrate, 20% PEG3350
|
Resolution 1.63 Å R-free 0.213 |
| 5EWV Crystal structure of the human BRPF1 bromodomain in complex with SEED20 Deposited 2015-11-21 | Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric |
Chain A
626–740（115 aa）
Fragment：UNP residues 626-740
|
Not recorded | 5SN 1,5-dimethyl-[1,2,4]triazolo[4,3-a]quinoline × 1 NO3 NITRATE ION × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP；277 K；0.1 M Bis-tris propane, pH6.5, 0.2 M Sodium nitrate, 20% PEG3350
|
Resolution 1.67 Å R-free 0.221 |
| 5EWW Crystal structure of the human BRPF1 bromodomain in complex with SEED21 Deposited 2015-11-21 | Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric |
Chain A
626–740（115 aa）
Fragment：UNP residues 626-740#
|
Not recorded | 5SK ~{N}-[(2~{R})-butan-2-yl]-1-methyl-[1,2,4]triazolo[4,3-a]quinoxalin-4-amine × 1 NO3 NITRATE ION × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP；277 K；0.1 M Bis-tris propane, pH6.5, 0.2 M Sodium nitrate, 20% PEG3350
|
Resolution 1.73 Å R-free 0.210 |
| 5FFV Crystal structure of the bromodomain of human BRPF1 in complex with H3K14ac histone peptide Deposited 2015-12-19 | Different construct Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer；Protein × 2 PDB declaration: dimeric |
Chain A
626–740（115 aa）
Fragment：UNP residues 626-740
|
Not recorded | EDO 1,2-ETHANEDIOL × 2 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP；pH 5.5；277.15 K；25% PEG3350, 0.2 M MgCl2, 0.1 M bis-tris pH 5.5
|
Resolution 1.30 Å R-free 0.206 |
| 5FFV Crystal structure of the bromodomain of human BRPF1 in complex with H3K14ac histone peptide Deposited 2015-12-19 | Different construct Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Protein heterocomplex Heteromer；Protein × 2 PDB declaration: dimeric |
Chain B
626–740（115 aa）
Fragment：UNP residues 626-740
|
Not recorded | EDO 1,2-ETHANEDIOL × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP；pH 5.5；277.15 K；25% PEG3350, 0.2 M MgCl2, 0.1 M bis-tris pH 5.5
|
Resolution 1.30 Å R-free 0.206 |
| 5FFW Crystal structure of the bromodomain of human BRPF1 in complex with H4K5acK8ac histone peptide Deposited 2015-12-19 | Different construct Different mutation/modification Different oligomeric state Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer；Protein × 3 PDB declaration: trimeric |
Chain A
626–740（115 aa）
Fragment：UNP residues 626-740
Chain B
626–740（115 aa）
Fragment：UNP residues 626-740
|
Not recorded | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP；pH 7.5；277.15 K；0.2 M NaCl, 25% PEG3350, 0.1 M Hepes pH 7.5
|
Resolution 1.50 Å R-free 0.243 |
| 5FFY Crystal structure of the bromodomain of human BRPF1 in complex with a benzimidazole ligand Deposited 2015-12-19 | Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric |
Chain A
626–740（115 aa）
Fragment：UNP residues 626-740
|
Not recorded | 5XD 4-ethyl-~{N}-(6-methoxy-1,3-dimethyl-2-oxidanylidene-benzimidazol-5-yl)benzenesulfonamide × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP；pH 9；277.15 K；0.1 M bis tris propane pH 9, 10% ethylene glycol, 0.15 M sodium nitrate
|
Resolution 1.55 Å R-free 0.213 |
| 5FG4 Crystal structure of the bromodomain of human BRPF1 in complex with OF-1 chemical probe Deposited 2015-12-20 | Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric |
Chain A
626–740（115 aa）
|
Not recorded | 5XE 4-bromanyl-~{N}-(6-methoxy-1,3-dimethyl-2-oxidanylidene-benzimidazol-5-yl)-2-methyl-benzenesulfonamide × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP；pH 7.4；277.15 K；25% PEG3350, 0.1M bis-tris propane pH 7.4, 5% ethyleneglycol, 0.15M sodium nitrate
|
Resolution 1.65 Å R-free 0.254 |
| 5FG5 Crystal structure of the bromodomain of human BRPF1 in complex with PFI-4 chemical probe Deposited 2015-12-20 | Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric |
Chain A
626–740（115 aa）
|
Not recorded | 5XF ~{N}-(1,3-dimethyl-2-oxidanylidene-6-pyrrolidin-1-yl-benzimidazol-5-yl)-2-methoxy-benzamide × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP；pH 7.5；277.15 K；15% PEG3350, 0.25 M sodium nitrate
|
Resolution 1.50 Å R-free 0.186 |
| 5FG5 Crystal structure of the bromodomain of human BRPF1 in complex with PFI-4 chemical probe Deposited 2015-12-20 | Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric |
Chain B
626–740（115 aa）
|
Not recorded | 5XF ~{N}-(1,3-dimethyl-2-oxidanylidene-6-pyrrolidin-1-yl-benzimidazol-5-yl)-2-methoxy-benzamide × 1 NO3 NITRATE ION × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP；pH 7.5；277.15 K；15% PEG3350, 0.25 M sodium nitrate
|
Resolution 1.50 Å R-free 0.186 |
| 5G4R BROMODOMAIN OF HUMAN BRPF1 WITH N-1,3-dimethyl-6-2R-2- methylpiperazin-1-yl-2-oxo-2,3-dihydro-1H-1,3-benzodiazol-5-yl-2- methoxybenzamide Deposited 2016-05-16 | Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric |
Chain A
622–738（117 aa）
Fragment：BROMODOMAIN OF BRPF1, UNP RESIDUES 622-738
|
Not recorded | LF1 N-[1,3-dimethyl-6-[(2R)-2-methylpiperazin-1-yl]-2-oxidanylidene-benzimidazol-5-yl]-2-methoxy-benzamide × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 8.5；30% P550MME_P20K, 0.1M BUFFER 3, PH8.5, 10% ETHYLENE GLYCOLS
|
Resolution 1.96 Å R-free 0.240 |
| 5G4R BROMODOMAIN OF HUMAN BRPF1 WITH N-1,3-dimethyl-6-2R-2- methylpiperazin-1-yl-2-oxo-2,3-dihydro-1H-1,3-benzodiazol-5-yl-2- methoxybenzamide Deposited 2016-05-16 | Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric |
Chain B
622–738（117 aa）
Fragment：BROMODOMAIN OF BRPF1, UNP RESIDUES 622-738
|
Not recorded | LF1 N-[1,3-dimethyl-6-[(2R)-2-methylpiperazin-1-yl]-2-oxidanylidene-benzimidazol-5-yl]-2-methoxy-benzamide × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 8.5；30% P550MME_P20K, 0.1M BUFFER 3, PH8.5, 10% ETHYLENE GLYCOLS
|
Resolution 1.96 Å R-free 0.240 |
| 5G4R BROMODOMAIN OF HUMAN BRPF1 WITH N-1,3-dimethyl-6-2R-2- methylpiperazin-1-yl-2-oxo-2,3-dihydro-1H-1,3-benzodiazol-5-yl-2- methoxybenzamide Deposited 2016-05-16 | Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 3 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric |
Chain C
622–738（117 aa）
Fragment：BROMODOMAIN OF BRPF1, UNP RESIDUES 622-738
|
Not recorded | LF1 N-[1,3-dimethyl-6-[(2R)-2-methylpiperazin-1-yl]-2-oxidanylidene-benzimidazol-5-yl]-2-methoxy-benzamide × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 8.5；30% P550MME_P20K, 0.1M BUFFER 3, PH8.5, 10% ETHYLENE GLYCOLS
|
Resolution 1.96 Å R-free 0.240 |
| 5G4R BROMODOMAIN OF HUMAN BRPF1 WITH N-1,3-dimethyl-6-2R-2- methylpiperazin-1-yl-2-oxo-2,3-dihydro-1H-1,3-benzodiazol-5-yl-2- methoxybenzamide Deposited 2016-05-16 | Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 4 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric |
Chain D
622–738（117 aa）
Fragment：BROMODOMAIN OF BRPF1, UNP RESIDUES 622-738
|
Not recorded | LF1 N-[1,3-dimethyl-6-[(2R)-2-methylpiperazin-1-yl]-2-oxidanylidene-benzimidazol-5-yl]-2-methoxy-benzamide × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 8.5；30% P550MME_P20K, 0.1M BUFFER 3, PH8.5, 10% ETHYLENE GLYCOLS
|
Resolution 1.96 Å R-free 0.240 |
| 5G4S BROMODOMAIN OF HUMAN BRPF1 WITH N-1,3-dimethyl-6-2R-2- methylpiperazin-1-yl-2-oxo-2,3-dihydro-1H-1,3-benzodiazol-5-yl-N- ethyl-2-methoxybenzamide Deposited 2016-05-16 | Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric |
Chain A
624–738（115 aa）
Fragment：BROMODOMAIN OF BRPF1, UNP RESIDUES 624-738
|
Not recorded | 8VI N-[1,3-dimethyl-6-[(2R)-2-methylpiperazin-1-yl]-2-oxidanylidene-benzimidazol-5-yl]-N-ethyl-2-methoxy-benzamide × 1 EDO 1,2-ETHANEDIOL × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 6.5；0.1M MORPHEUS BUFFER 1, PH 6.5 37.5% MPD_P1K_P3350 10% MORPHEUS NITRATE-PHOSPHATE-SULPHATE
|
Resolution 1.60 Å R-free 0.194 |
| 5MWG Crystal structure of the human BRPF1 bromodomain in complex with BZ091 Deposited 2017-01-18 | Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric |
Chain A
626–740（115 aa）
|
Not recorded | WGX ~{N}-[1,4-dimethyl-2,3-bis(oxidanylidene)-7-piperidin-1-yl-quinoxalin-6-yl]-5,6,7,8-tetrahydronaphthalene-2-sulfonamide × 1 NO3 NITRATE ION × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP；277 K；0.1 M Bis-tris propane, pH6.5, 0.2 M Sodium Nitrate, 20% PEG3350
|
Resolution 1.50 Å R-free 0.227 |
| 5MWG Crystal structure of the human BRPF1 bromodomain in complex with BZ091 Deposited 2017-01-18 | Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric |
Chain B
626–740（115 aa）
|
Not recorded | WGX ~{N}-[1,4-dimethyl-2,3-bis(oxidanylidene)-7-piperidin-1-yl-quinoxalin-6-yl]-5,6,7,8-tetrahydronaphthalene-2-sulfonamide × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP；277 K；0.1 M Bis-tris propane, pH6.5, 0.2 M Sodium Nitrate, 20% PEG3350
|
Resolution 1.50 Å R-free 0.227 |
| 5MWH Crystal structure of the human BRPF1 bromodomain in complex with BZ089 Deposited 2017-01-18 | Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric |
Chain A
626–740（115 aa）
|
Not recorded | UWX ~{N}-[1,4-dimethyl-7-morpholin-4-yl-2,3-bis(oxidanylidene)quinoxalin-6-yl]-4-(2-methylpropyl)benzenesulfonamide × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP；277 K；0.1 M Bis-tris propane, pH6.5, 0.2 M Sodium nitrate, 20% PEG3350
|
Resolution 1.65 Å R-free 0.226 |
| 5MWH Crystal structure of the human BRPF1 bromodomain in complex with BZ089 Deposited 2017-01-18 | Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric |
Chain B
626–740（115 aa）
|
Not recorded | UWX ~{N}-[1,4-dimethyl-7-morpholin-4-yl-2,3-bis(oxidanylidene)quinoxalin-6-yl]-4-(2-methylpropyl)benzenesulfonamide × 1 NO3 NITRATE ION × 2 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP；277 K；0.1 M Bis-tris propane, pH6.5, 0.2 M Sodium nitrate, 20% PEG3350
|
Resolution 1.65 Å R-free 0.226 |
| 5MWZ Crystal structure of the human BRPF1 bromodomain in complex with BZ073 Deposited 2017-01-20 | Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric |
Chain A
626–740（115 aa）
|
Not recorded | KGU ~{N}-[1,4-diethyl-2,3-bis(oxidanylidene)-7-piperidin-1-yl-quinoxalin-6-yl]-2-(4-methylpiperazin-1-yl)ethanamide × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP；277 K；0.1 M Bis-Tris Propane pH7.4, 25% PEG3350, 5% EG, 0.15 M NaNO3
|
Resolution 1.25 Å R-free 0.181 |
| 5MYG Crystal structure of the bromodomain of human BRPF1 in complex with NI-57 chemical probe Deposited 2017-01-26 | Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric |
Chain A
626–740（115 aa）
|
Not recorded | LS8 4-cyano-~{N}-(1,3-dimethyl-2-oxidanylidene-quinolin-6-yl)-2-methoxy-benzenesulfonamide × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP；pH 7.5；277 K；0.1 M ammonium acetate, 17% PEG 10K, 0.1 M bis-tris pH 5.5
|
Resolution 2.30 Å R-free 0.307 |
| 5MYG Crystal structure of the bromodomain of human BRPF1 in complex with NI-57 chemical probe Deposited 2017-01-26 | Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric |
Chain B
626–740（115 aa）
|
Not recorded | LS8 4-cyano-~{N}-(1,3-dimethyl-2-oxidanylidene-quinolin-6-yl)-2-methoxy-benzenesulfonamide × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP；pH 7.5；277 K；0.1 M ammonium acetate, 17% PEG 10K, 0.1 M bis-tris pH 5.5
|
Resolution 2.30 Å R-free 0.307 |
| 5MYG Crystal structure of the bromodomain of human BRPF1 in complex with NI-57 chemical probe Deposited 2017-01-26 | Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 3 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric |
Chain C
626–740（115 aa）
|
Not recorded | LS8 4-cyano-~{N}-(1,3-dimethyl-2-oxidanylidene-quinolin-6-yl)-2-methoxy-benzenesulfonamide × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP；pH 7.5；277 K；0.1 M ammonium acetate, 17% PEG 10K, 0.1 M bis-tris pH 5.5
|
Resolution 2.30 Å R-free 0.307 |
| 5MYG Crystal structure of the bromodomain of human BRPF1 in complex with NI-57 chemical probe Deposited 2017-01-26 | Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 4 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric |
Chain D
626–740（115 aa）
|
Not recorded | LS8 4-cyano-~{N}-(1,3-dimethyl-2-oxidanylidene-quinolin-6-yl)-2-methoxy-benzenesulfonamide × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP；pH 7.5；277 K；0.1 M ammonium acetate, 17% PEG 10K, 0.1 M bis-tris pH 5.5
|
Resolution 2.30 Å R-free 0.307 |
| 5O4S Crystal structure of the human BRPF1 bromodomain in complex with BZ135 Deposited 2017-05-30 | Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric |
Chain A
626–740（115 aa）
|
Not recorded | 9KW ~{N}-[1,4-dimethyl-7-morpholin-4-yl-2,3-bis(oxidanylidene)quinoxalin-6-yl]-5,6,7,8-tetrahydronaphthalene-2-sulfonamide × 1 NO3 NITRATE ION × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP；297 K；0.1 M Bis-tris propane, pH6.5, 0.15 M Sodium Nitrate, 20% PEG3350
|
Resolution 1.75 Å R-free 0.221 |
| 5O4S Crystal structure of the human BRPF1 bromodomain in complex with BZ135 Deposited 2017-05-30 | Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric |
Chain B
626–740（115 aa）
|
Not recorded | 9KW ~{N}-[1,4-dimethyl-7-morpholin-4-yl-2,3-bis(oxidanylidene)quinoxalin-6-yl]-5,6,7,8-tetrahydronaphthalene-2-sulfonamide × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP；297 K；0.1 M Bis-tris propane, pH6.5, 0.15 M Sodium Nitrate, 20% PEG3350
|
Resolution 1.75 Å R-free 0.221 |
| 5O4T Crystal structure of the human BRPF1 bromodomain in complex with BZ061 Deposited 2017-05-30 | Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric |
Chain A
626–740（115 aa）
|
Not recorded | 9KT 1,4-dimethylquinoxaline-2,3-dione × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP；277 K；0.1 M Bis-tris propane, pH6.5, 0.2 M Sodium nitrate, 20% PEG3350
|
Resolution 1.50 Å R-free 0.212 |
| 5O55 Crystal structure of the human BRPF1 bromodomain in complex with BZ047 Deposited 2017-05-31 | Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric |
Chain A
626–740（115 aa）
Fragment：UNP residues 626-740
|
Not recorded | NO3 NITRATE ION × 1 9L5 ~{N}-[(1~{S})-1-(1,5-dimethylpyrazol-4-yl)ethyl]-1-ethyl-3-methyl-2-oxidanylidene-quinoxaline-6-carboxamide × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP；277 K；0.1 M Bis-tris propane, pH6.5, 0.15 M Sodium Nitrate, 20% PEG3350
|
Resolution 1.45 Å R-free 0.201 |
| 5O5A Crystal structure of the human BRPF1 bromodomain in complex with BZ032 Deposited 2017-06-01 | Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric |
Chain A
626–740（115 aa）
|
Not recorded | NO3 NITRATE ION × 1 9LN 1-ethyl-~{N}-methyl-2,3-bis(oxidanylidene)-~{N}-[(1-phenylpyrazol-4-yl)methyl]-4~{H}-quinoxaline-6-carboxamide × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP；277 K；0.1 M Bis-tris propane, pH6.5, 0.2 M Sodium nitrate, 20% PEG3350
|
Resolution 1.60 Å R-free 0.202 |
| 5O5F Crystal structure of the human BRPF1 bromodomain in complex with BZ038 Deposited 2017-06-01 | Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric |
Chain A
626–740（115 aa）
|
Not recorded | 9LT 1-ethyl-~{N}-[(~{R})-(3-fluorophenyl)-(1-methylimidazol-2-yl)methyl]-2,3-bis(oxidanylidene)-4~{H}-quinoxaline-6-carboxamide × 1 NO3 NITRATE ION × 2 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP；277 K；0.1 M Bis-tris propane, pH6.5, 0.2 M Sodium Nitrate, 20% PEG3350
|
Resolution 1.30 Å R-free 0.188 |
| 5O5H Crystal structure of the human BRPF1 bromodomain in complex with BZ053 Deposited 2017-06-01 | Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric |
Chain A
626–740（115 aa）
|
Not recorded | 9LK ~{N}-[6-(4-chloranylphenoxy)pyridin-3-yl]-2,4-dimethyl-1,3-oxazole-5-carboxamide × 2 NO3 NITRATE ION × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP；277 K；0.1 M Bis-Tris Propane, pH6.5, 0.2 M Sodium Nitrate, 20% PEG3350
|
Resolution 1.85 Å R-free 0.235 |
| 5OV8 Crystal structure of the human BRPF1 bromodomain in complex with BZ097 Deposited 2017-08-28 | Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric |
Chain A
626–740（115 aa）
|
Not recorded | AXN ~{N}-[1,4-dimethyl-2,3-bis(oxidanylidene)-7-pyrrolidin-1-yl-quinoxalin-6-yl]-4-(2-methylpropyl)benzenesulfonamide × 1 NO3 NITRATE ION × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP；277 K；0.1 M Bis-Tris Propane pH9, 10% EG, 0.15M NaNO3, 25% PEG3350
|
Resolution 1.80 Å R-free 0.244 |
| 5OV8 Crystal structure of the human BRPF1 bromodomain in complex with BZ097 Deposited 2017-08-28 | Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric |
Chain B
626–740（115 aa）
|
Not recorded | AXN ~{N}-[1,4-dimethyl-2,3-bis(oxidanylidene)-7-pyrrolidin-1-yl-quinoxalin-6-yl]-4-(2-methylpropyl)benzenesulfonamide × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP；277 K；0.1 M Bis-Tris Propane pH9, 10% EG, 0.15M NaNO3, 25% PEG3350
|
Resolution 1.80 Å R-free 0.244 |
| 5OWA Crystal structure of the human BRPF1 bromodomain in complex with BZ054 Deposited 2017-08-31 | Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric |
Chain A
626–740（115 aa）
|
Not recorded | B0H ~{N}-[4-[[(3~{S},5~{R})-3,5-dimethylpiperidin-1-yl]methyl]-1,3-thiazol-2-yl]-2,4-dimethyl-1,3-oxazole-5-carboxamide × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP；277 K；0.2 M MgCl2, 20% PEG3350
|
Resolution 1.95 Å R-free 0.268 |
| 5OWA Crystal structure of the human BRPF1 bromodomain in complex with BZ054 Deposited 2017-08-31 | Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric |
Chain B
626–740（115 aa）
|
Not recorded | B0H ~{N}-[4-[[(3~{S},5~{R})-3,5-dimethylpiperidin-1-yl]methyl]-1,3-thiazol-2-yl]-2,4-dimethyl-1,3-oxazole-5-carboxamide × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP；277 K；0.2 M MgCl2, 20% PEG3350
|
Resolution 1.95 Å R-free 0.268 |
| 5OWA Crystal structure of the human BRPF1 bromodomain in complex with BZ054 Deposited 2017-08-31 | Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 3 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric |
Chain C
626–740（115 aa）
|
Not recorded | B0H ~{N}-[4-[[(3~{S},5~{R})-3,5-dimethylpiperidin-1-yl]methyl]-1,3-thiazol-2-yl]-2,4-dimethyl-1,3-oxazole-5-carboxamide × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP；277 K；0.2 M MgCl2, 20% PEG3350
|
Resolution 1.95 Å R-free 0.268 |
| 5OWA Crystal structure of the human BRPF1 bromodomain in complex with BZ054 Deposited 2017-08-31 | Different construct Different oligomeric state Different experimental conditions Different structure-quality metrics | Assembly 4 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric |
Chain D
626–740（115 aa）
|
Not recorded | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP；277 K；0.2 M MgCl2, 20% PEG3350
|
Resolution 1.95 Å R-free 0.268 |
| 5OWB Crystal structure of the human BRPF1 bromodomain in complex with DSPBP1004 Deposited 2017-08-31 | Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric |
Chain A
626–740（115 aa）
|
Not recorded | NO3 NITRATE ION × 1 AYW 4-methyl-6-oxidanyl-1-benzofuran-3-one × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP；277 K；0.1M Sodium Acetate, pH5.5, 0.15 M Sodium Nitrate, 20% PEG3350
|
Resolution 1.65 Å R-free 0.204 |
| 5OWE Crystal structure of the human BRPF1 bromodomain in complex with DSPBP1010 Deposited 2017-08-31 | Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric |
Chain A
626–740（115 aa）
|
Not recorded | B0E 1,3-bis(oxidanyl)benzo[c]chromen-6-one × 1 NO3 NITRATE ION × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP；277 K；0.1 M Bis-tris propane, pH6.5, 0.2 M Sodium nitrate, 20% PEG3350
|
Resolution 1.70 Å R-free 0.213 |
| 5T4U Crystal structure of the bromodomain of human BRPF1 in complex with a quinolinone ligand Deposited 2016-08-30 | Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric |
Chain A
627–740（114 aa）
|
Not recorded | NO3 NITRATE ION × 1 12Q 1-METHYLQUINOLIN-2(1H)-ONE × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP；pH 7.5；277.15 K；20 % PEG3350, 0.2 M ammonium nitrate
|
Resolution 1.50 Å R-free 0.231 |
| 5T4V Crystal structure of the bromodomain of human BRPF1 in complex with NI-48 ligand Deposited 2016-08-30 | Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric |
Chain A
627–740（114 aa）
|
Not recorded | N48 4-cyano-N-(7-methoxy-1,4-dimethyl-2-oxo-1,2-dihydroquinolin-6-yl)benzene-1-sulfonamide × 1 EDO 1,2-ETHANEDIOL × 1 FMT FORMIC ACID × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP；pH 7.5；277.15 K；0.1 m bis-tris propane pH 8.5, 0.2 M sodium formate, 20% PEG 3350, 10% ethylene glycol
|
Resolution 1.65 Å R-free 0.250 |
| 6EKQ Crystal structure of the human BRPF1 bromodomain complexed with BZ054 in space group C2 Deposited 2017-09-26 | Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric |
Chain A
626–740（115 aa）
|
Not recorded | B0H ~{N}-[4-[[(3~{S},5~{R})-3,5-dimethylpiperidin-1-yl]methyl]-1,3-thiazol-2-yl]-2,4-dimethyl-1,3-oxazole-5-carboxamide × 1 NO3 NITRATE ION × 2 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP；277 K；0.1 M Bis-Tris Propane pH9, 10% EG, 0.15M NaNO3, 25% PEG3350
|
Resolution 1.65 Å R-free 0.182 |
| 6EKQ Crystal structure of the human BRPF1 bromodomain complexed with BZ054 in space group C2 Deposited 2017-09-26 | Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric |
Chain B
626–740（115 aa）
|
Not recorded | B0H ~{N}-[4-[[(3~{S},5~{R})-3,5-dimethylpiperidin-1-yl]methyl]-1,3-thiazol-2-yl]-2,4-dimethyl-1,3-oxazole-5-carboxamide × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP；277 K；0.1 M Bis-Tris Propane pH9, 10% EG, 0.15M NaNO3, 25% PEG3350
|
Resolution 1.65 Å R-free 0.182 |
| 6U04 Crystal structure of human BRPF1 PZP bound to histone H3 tail Deposited 2019-08-13 | Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Insufficient information Monomer；Protein × 1 PDB declaration: monomeric |
Chain A
271–454（184 aa）
|
Not recorded | PR PRASEODYMIUM ION × 1 ZN ZINC ION × 5 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP；pH 8.5；291.15 K；0.2 M Lithium sulfate, 0.1 M Tris-HCl pH 8.5, 40% (v/v) PEG400, and 0.01M Praseodymium(III) acetate hydrate
|
Resolution 2.20 Å R-free 0.208 |
| 7C4I High resolution structure of BRPF1 Bromo Domain from Biortus Deposited 2020-05-18 | Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric |
Chain A
626–740（115 aa）
|
Not recorded | K POTASSIUM ION × 4 GOL GLYCEROL × 6 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP；293 K；0.2 M Potassium fluoride, 20 %(w/v) PEG 3350
|
Resolution 1.37 Å R-free 0.194 |
| 8QAZ Crystal Structure of BRPF1 bromodomain in complex with acetyl-pyrrole derivative compound 3 Deposited 2023-08-23 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric |
Chain A
626–740（115 aa）
|
Mutation：bromodomain (residues 626-740) | QA5 2-[4-[4-ethanoyl-5-methyl-3-(3-methylbutyl)-1~{H}-pyrrol-2-yl]-1,3-thiazol-2-yl]guanidine × 1 NO3 NITRATE ION × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP；pH 7.5；277 K；0.18 M sodium nitrate, 30% PEG 3350, 5% ethylene glycol
|
Resolution 1.40 Å R-free 0.196 |
| 8QB0 Crystal Structure of BRPF1 bromodomain in complex with acetyl-pyrrole derivative compound 2 Deposited 2023-08-23 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric |
Chain A
626–740（115 aa）
|
Mutation：bromodomain (residues 626-740) | Q9U 2-[4-(3,6,6-trimethyl-4-oxidanylidene-5,7-dihydro-2~{H}-isoindol-1-yl)-1,3-thiazol-2-yl]guanidine × 1 NO3 NITRATE ION × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP；pH 7.5；277 K；0.18 M sodium nitrate, 30% PEG 3350, 5% ethylene glycol
|
Resolution 1.45 Å R-free 0.208 |
| 8QB2 Crystal Structure of BRPF1 bromodomain in complex with acetyl-pyrrole derivative compound 79 Deposited 2023-08-24 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric |
Chain A
626–740（115 aa）
|
Mutation：bromodomain (residues 626-740) | GKI 1-[2-methyl-4-(3-methylbutyl)-5-(2-piperazin-1-yl-1,3-thiazol-4-yl)-1~{H}-pyrrol-3-yl]ethanone × 1 NO3 NITRATE ION × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP；pH 5.5；277 K；0.18 M sodium nitrate, 30% PEG 3350
|
Resolution 1.42 Å R-free 0.196 |
64 other PDB entries and 94 assemblies. Open the comparison page and filter oligomeric states
View Construct and Data Evidence
| UniProt name | BRPF1_HUMAN |
| Isoform | — |
| PDB entities | 1 |
| Chains and sequence ranges | Author chain A； PDBConstruct 2–130； UniProt 1079–1207 |
